Clinical Trial Update: Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)

View source ↗

Summary

An ongoing clinical trial investigating anti-C1s, anti-HMGB1, and anti-C1q autoantibodies as a treatment strategy for systemic lupus erythematosus, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Anti-C1q autoantibodies (anti-C1q autoantibodies)
• Anti-C1s autoantibodies (anti-C1s autoantibodies)
• Anti-HMGB1 autoantibodies (anti-HMGB1 autoantibodies)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Lupus Erythematosus, Systemic | Status: RECRUITING